City of Winter Haven v. Cleveland Indians Baseball Company Limited Partnership
Far r i s
,fohnson M D
UNITED STATES DTSTRICT COURT MIDDLE DISTRICT OF FLORIDA O R I , A N D O DIVISION
IN RE: Seroquel
L l - g -dF i L . J - O n
MDL DOCKET NO. ]-769
DEPOSITION OF FARRIS T. JOHNSON, 'JR. , Wednesday, September 26, 2Qo1
M. D .
6 1 0 Oglethor p e
Qrli l- a R
Reported By: JudiLh L. LeiLz, RPR Georgia CCR-B-2312 Services Esquire Deposition Atlanta Office Job No. 425003 Phone - 404-872-"/890
Far r i s
.fohnson M D
(Pages 2 to 5)
Page T I N I T E DSTATESDISTRICTCOURT OF M I D D L E DISTRICT FLORIDA O R L A N D ODIVISION Products Liability I N RE: Seroquel Litigation MDLDOCKETNO1769 .
6 ,7 5 1 2
INDEX M.D. T, WITNESS: FARRIS JOHNSON,
EXAMINATION B y Ms. Owens B y Ms. DcCarli B y Ms. Owens B y Ms. DcCarli PAGE 6 82 120 135
2 3 4
to 1295 T h i sDocument Relates 6;06-cv7 8 10 11 !2 13 T4 15 16 l7 18 19 20
I 9 10 11 L2 13
M.D., T. D e p o s i t i oof FARRIS JOIINSON, n AstraZeneca, t a k e non behalfof the Defendant p u r s u a nto the stipulations t bclore agreed herein, to at J u d i t h Leitz,Certified L. CourtReporter, 610 on SuiteB, Athens,Georgia, Oglethorpe Avenue, 2007, W e d n e s d a y , 26thdayof September, the c o m m e n c i nat thehourof 2:22p.m. g
I'7 18 20 2! 22
22 23 24
EXHItsI'I'S PACE N O . DESCRIPTION A1 of I Notice Deposition 47 Discharge Summary Io 2 051291010612/01 49 letter Whomit May Concern 9116106To 3 49 Lxamination; 4 6/16/00HistoryandPhysical History 5/26101 Summary; 1 0 / 1 9 / 0 Discharge 0 Examination a n dPhysical )b Medioal Record 5 319104 58 Record 6 5lll104Medical '7 )6 8l13l04MedicalRecord 62 Medical Record 8 9ll3l(14 64 Record Medical 9 10125i04 72 Record l 0 l0/l 7/05Medical '16 Record | | l2lll05 Medical 8l l 2 CV of Dr. Johnson 86 1 3 4lWA5 OfficeNote - Prescribing 87 Record l 4 Spreadsheet
J o b o .4 2 5 0 0 3 N
1 2 l 4
5 6 7
APPEARANCES O!- COUNSEL O n behalfofthe Plaintifl D E B R A DcCARI,I,ESQUIRE L A U R A M. BRANDENBERG.ESQUIRI L e v i n SimesKaiser& Gornick,L,L,P 4 4 MontgomeryStreet 36thFloor S a nFrancisco, Califomia94104 (4ts\ 646-7160 (415) 81- 270ax f 9 1 e-mail:firstname.lastname@example.org Jaw. l b r a n d e n b e r g @ l s k g com Astrfleneca: On behalfof the Defendant LAT'RA LEWIS OWENS,ESQUIRE A l s t o n& Bird,L,L P. OneAtlantic Center Streel l 2 0 l WestPeachtree Atlanta, Georgia30309 ( 4 0 4 )881-7000 (404)881-7777 fa\ e - m a i l :email@example.com & ALSO PRESENT:MarshallWillis with A.lston Bird
1 2 3
4 5 ,7 I 9 10
EXHIBITS(CONT.) PAGE N O . DESCRIPTION - Voicemail 94 Script l 5 Draft l 6 O b j e c t i o nHiurdlcr on Atypical antipsychotics 9 5
a n d glucosedysregulation
9 10 11 !2 13
97 l 7 Astrazenecalmpoiant DrugInformation 30, J a n u a r y 2004 99 Diabetes Master Fehruary 200,4, 3, l 8 Final: Document and Q u e s t i o n Answer ofReports of l 0 l 2004- A Survey l 9 Article June Hyperglycemia and Quetiapine-Associated D i a b e t eMellltus s r03 2004- Rclationship 2 0 Article- September Medication Treatment Antipsychotic Between a n dNew Cases Inpatienls Among Psychiatric o f Diabctcs
2l 104 of Article 2006 - AmericanJournal - DiabetesRisk Associatedwith Epidemiology U s e of Olanzapine,Quetiapine,ard Risperid0ne i n VeteransHealth Administration Patientswith Schizophrenia 2 2 Astrazeneca What you needto know to Detail Mania Sell Sheel for Seroquel t h e PCP - CallNotes 109 2 3 Spreadsheet - MedicalRecords 138 2 4 Groupexhibit
15 76 L'7
31 (Pages l-18 to
Page 1 2 3 4 5 6 7 118 I 2 3 4 6 7 I 10 1lI2 in uncommonand certainlyhavc to be interpreted the with contextofthe patient. Most patients extrapyramidal side effects. EPS, interestingly enoughdon't complainoftremors. They haveother but is complaints, tremorsin my experience not a with that medication predominant complaintassociated by the patient.
Page 120 thatthatwaspropernotice. Sowe reserve t o expect based uponthe latereceived o u r right to continue records. F U R T H E REXAMINATION B Y MS .OW E N S : your you about earlier Q . Doctor, talked of you wouldhave yourconsiderations in discussions to prescribe you ofmedications r i s k sandbcncfits correct? y o u r patients, A . Correct, to Q . So I assume the extentthatthereare particular about drugsmadeby theFDA or on warnings those that labeling you lbundsignificant t h eproduct you with discuss your w o u l dbewarnings wouldalso p a t i e n t scorrect? , A . Yes. Q . And thatwouldbetrueas-- notjust asto but specifically? a l l medications asto Seroquel A . Knownto me at thattime,yes. to was informalion provided you Q . Now, some Seroquel been receiving mayhave t h a tMs.Thomas from someone otherthanyou in 2004,correct? samples yes. A . Today, of any Q . And do youhave record prescribing fbr S e r o q u e l herin 2004? Page 121 A. No. you the Q . Soto theextent records reviewed or s ctoss-examination d u r i n gPlaintiff counsel's of numbers patients ofyou showed exanination that prcscriptions fiom you for Seroquel receiving you as Hellen Thomas best w o u l dnothaveincluded today? t e l l from your records A . Correct. that the Q . And does information this patient fromherpsychiatrist been obtaining samples m a yhave youroptnton 2004change during Advantagc o r from wasnot the earlierthat Seroquel t h a tyou of'fered diabetes? of c a u s e Ms,Thomas's A , Saythat again. may that Q . Doesthe information Ms. Thomas in Seroquel samples 2004fromher been rccciving have healthcare p s y c h i a t r i sor from Advantage t p r o f e s s i o n a changc opinionyou offeredearlier ls thc was of t h a t Seroquel not the cause Ms, Thomas's diabetes? A. No. you thatin your Q, And I believe said has the that it hasnotbeen case Seroquel expcrience yourpatients? in diabetes caused A, Correct.
9 10 lL 12 13 14 15
1-7 18 19 2A
has everbeen Q . To your knowledge, Ms. Thomas for tested EPS? A . Thereis not a formaltestfor it. It's diagnosis. I ofa -- it'sconfinned physical by more people familiar seen enough wouldsaythis,she's problem, rvithIPS that ifthat hadbeena predominant psychiatrists neurologists and expected I wouldhave to pickthatup preuyeasily, Q . Giventhedrugsthatshervason? A . Correct. Q . Okay. A . Ifs thckind ofthing thatyou- you with patients who arebeingtreated observe thinkit would p s y c h i a t r imedications I don't c and goneunnoticed thenumber people she of that by have I seen, don'tthink. had of rs Q , Dr. Johnson, it a fair summary your '"varnings that from Astrleneca testimony adequale Page 119
15 16 71 !9 20 2L
I 2 3 4 5 6 7 8 9 10 11 t2 L4 15 L7 l8 t9
1 your riskswould haveallered diabetes regarding 2 for prescribing recommendations Ms.'l'homas? 3 A. Yes. 4 the M S . DeCARLI: I am going10pass 5 openin the w i t n e s sbut I am leaving deposition , 6 the l i g h t ofthe factthatjust 38 hoursbefore '7 a we of b e g i n n i n g this deposition received AstraZeneca's I of s i g n i f cantamount new records. i 9 was on August 3rd and they waited disclosure first 10 records. 24th u n t i l September at midnightto disclose 11 we Dr. S o ,unfortunately, Johnson, may haveto the on day,but I am reserving right 1 2 c o n t i n u e another 13 t o reopen. that M S . OWENS: And I recognize the time 1 4 w a s close,but would nole that the obligationwas to L 5 p r o v i d eit beforethe depositionand you will agree conect? r-1 t h a t it was receivedbeforethis deposition, that it rvas M S . DeCARLI: I will agree 19 ninehoursbeforeI met with the Plaintiff received 20 present for her depositionandwe were with her to 2r morning, flom 9:00a.m.yesterday t h e Plaintiffs 22 late, until 40 minutes d i d n ' tstartthe deposition 23 which did a n ddidn'tfinish until 6:30 lastevening, and I don't 2 4 n o t leavevery much time for preparation on t h i n k it'svery reasonable the pad ofAstraZeneca 2 5
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?